About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Faslodex in McCune-Albright Syndrome

Faslodex in McCune-Albright Syndrome

NCT00278915·16 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

AstraZeneca

Age

1–10

Sex

FEMALE

Healthy volunteers

Not accepted

You may be eligible if

Females less than or equal to 10 years of age (prior to 11th birthday)
Diagnosis of MAS
PPP associated with MAS

You may not be if

Received any prior treatment for PPP associated with MAS with fulvestrant
Abnormal platelet count or liver function tests
Bleeding disorders
Long term anticoagulation therapy
Known hypersensitivity to any component of the study drug

The record

StatusCompleted

PhasePhase 2

Taking part30

StartedJan 2006

UpdatedMar 5, 2024

Conditions

Puberty, Precocious McCune-Albright Syndrome

Where16

Research Site
Birmingham, Alabama, United States
Research Site
Miami, Florida, United States
Research Site
Lexington, Kentucky, United States